BioAge Labs Files 8-K on Shareholder Votes
Ticker: BIOA · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1709941
| Field | Detail |
|---|---|
| Company | Bioage Labs, INC. (BIOA) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
BioAge Labs filed an 8-K for shareholder votes on June 5th.
AI Summary
BioAge Labs, Inc. filed an 8-K on June 9, 2025, reporting on matters submitted to a vote of security holders as of June 5, 2025. The filing details the company's corporate information, including its address in Emeryville, California, and its standard industrial classification in Pharmaceutical Preparations.
Why It Matters
This filing indicates that BioAge Labs held or is preparing for a shareholder vote, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not contain information about financial distress or significant operational changes.
Key Numbers
- 001-42279 — SEC File Number (Identifies the company's filing with the SEC)
- 47-4721157 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- BioAge Labs, Inc. (company) — Registrant
- June 05, 2025 (date) — Earliest event reported
- June 09, 2025 (date) — Date of report
- Emeryville, California (location) — Principal Executive Offices
- Pharmaceutical Preparations (industry) — Standard Industrial Classification
FAQ
What specific matters were submitted to a vote of BioAge Labs' security holders on or around June 5, 2025?
The filing does not specify the exact matters submitted to a vote, only that it is a 'Submission of Matters to a Vote of Security Holders'.
When was this 8-K report officially filed with the SEC?
The report was filed as of date June 09, 2025.
What is BioAge Labs, Inc.'s primary business classification according to the SEC filing?
BioAge Labs, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are BioAge Labs, Inc.'s principal executive offices located?
The principal executive offices are located at 5885 Hollis Street, Suite 370, Emeryville, California, 94608.
What is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding BioAge Labs, Inc. (BIOA).